Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1166272/000149315222005418/form6-k.htm
SEC Filings
GENE Annual Reports
20-F Annual Report August 2021
20-F Annual Report October 2020
20-F Annual Report October 2019
20-F Annual Report October 2018
20-F Annual Report October 2017
20-F Annual Report October 2016
20-F Annual Report November 2015
20-F Annual Report October 2014
20-F Annual Report October 2013
20-F Annual Report October 2012
20-F Annual Report August 2021
20-F Annual Report October 2020
20-F Annual Report October 2019
20-F Annual Report October 2018
20-F Annual Report October 2017
20-F Annual Report October 2016
20-F Annual Report November 2015
20-F Annual Report October 2014
20-F Annual Report October 2013
20-F Annual Report October 2012
GENE Corporate News
Last10K.com | 6-K Foreign Issuer Report Thu Feb 24 2022
View differences made from one to another to evaluate Genetic Technologies Ltd's financial trajectory
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Genetic Technologies Ltd.
Assess how Genetic Technologies Ltd's management team is paid from their Annual Proxy
Genetic Technologies Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
Tools
Financial Statements, Disclosures and Schedules
Inside this 6-K Foreign Issuer Report
Cover
Condensed Consolidated Balance Sheet
Condensed Consolidated Statement Of Cash Flows
Condensed Consolidated Statement Of Changes In Equity
Condensed Consolidated Statement Of Profit Or Loss And Comprehensive Income
Basis Of Preparation Of Half-Year Report
Business Acquisition
Business Acquisition (Details Narrative)
Business Acquisition (Tables)
Equity
Equity (Details Narrative)
Equity (Tables)
Events Occurring After The Reporting Period
Goodwill
Goodwill (Tables)
Loss Per Share
Loss Per Share (Tables)
Other Income
Other Income (Tables)
Other Intangible Assets
Other Intangible Assets (Details Narrative)
Other Intangible Assets (Tables)
Related Party Transactions
Related Party Transactions (Details Narrative)
Revenue
Revenue (Tables)
Schedule Of Issued And Paid-Up Capital (Details)
Schedule Of Movements In Shares On Issue (Details)
Segment Information
Segment Information (Tables)
Summary Of Business Acquisition Assets And Goodwill Acquired (Details)
Summary Of Changes In Goodwill (Details)
Summary Of Earnings Per Share And Weighted Average Number Of Shares (Details)
Summary Of Employee Share And Options Plan (Details)
Summary Of Geographical Information (Details)
Summary Of Other Income (Details)
Summary Of Other Income (Details) (Parenthetical)
Summary Of Other Intangible Assets (Details)
Summary Of Other Reserves (Details)
Summary Of Revenue (Details)
Material Contracts, Statements, Certifications & more
Genetic Technologies Ltd provided additional information to their SEC Filing as exhibits
Ticker: GENE
CIK: 1166272
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001493152-22-005418
Submitted to the SEC: Thu Feb 24 2022 4:39:29 PM EST
Accepted by the SEC: Thu Feb 24 2022
Period: Friday, December 31, 2021
Industry: Biological Products No Disgnostic Substances
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/gene/0001493152-22-005418.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...